These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7236375)

  • 81. [Antibiotic therapy in general practice: infections of the otorhinolaryngology system and lower respiratory tract. French Agency of Public Health Safety of Medicinal Products].
    Ann Otolaryngol Chir Cervicofac; 1999 Oct; 116(5):302-14. PubMed ID: 10572596
    [No Abstract]   [Full Text] [Related]  

  • 82. Vitamin C: from popular food supplement to specific drug.
    Goldenberg H
    Forum Nutr; 2003; 56():42-5. PubMed ID: 15806791
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Comparison of the effect of hydrogel and a solution of sodium ascorbate on dentin-composite bond strength after bleaching.
    Kimyai S; Valizadeh H
    J Contemp Dent Pract; 2008 Feb; 9(2):105-12. PubMed ID: 18264532
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Uncoupling of incorporation of ascorbic acid and apoptosis induction.
    Amano Y; Sakagami H; Tanaka T; Yamanaka Y; Nishimoto Y; Yamaguchi M; Takeda M
    Anticancer Res; 1998; 18(4A):2503-6. PubMed ID: 9703900
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Ascorbate--the proof of the pudding! A selection of case histories responding to ascorbate.
    Kalokerinos A; Dettman I; Dettman G
    Australas Nurses J; 1982 Mar; 11(2):18-21. PubMed ID: 6920272
    [No Abstract]   [Full Text] [Related]  

  • 86. [Importance of monitoring antibiotic drugs in otorhinolaryngologic therapy].
    Pokrajac M; Dotlić R
    Srp Arh Celok Lek; 2002; 130 Suppl 1():49-52. PubMed ID: 12395465
    [No Abstract]   [Full Text] [Related]  

  • 87. Enhancement of radical intensity and cytotoxic activity of ascorbate by hyperthermia.
    Satoh K; Sakagami H; Nakamura K
    Anticancer Res; 1996; 16(5A):2987-91. PubMed ID: 8917417
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Differential effects and transport kinetics of ascorbate derivatives in leukemic cell lines.
    Koh WS; Lee SJ; Lee H; Park C; Park MH; Kim WS; Yoon SS; Park K; Hong SI; Chung MH; Park CH
    Anticancer Res; 1998; 18(4A):2487-93. PubMed ID: 9703897
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Interaction between sodium ascorbate and polyphenols.
    Satoh K; Ida Y; Ishihara M; Sakagami H
    Anticancer Res; 1999; 19(5B):4177-86. PubMed ID: 10628372
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Phase 1 trial of high-dose intravenous vitamin C treatment for patients with cancer.
    Stephenson CM; Levin RD; Lis CG
    J Am Osteopath Assoc; 2007 Jun; 107(6):212-3. PubMed ID: 17635899
    [No Abstract]   [Full Text] [Related]  

  • 91. [Utility of febrectol-tetracycline in otorhinolaryngologic therapy].
    Decroix G; Bochu JP
    Lille Med; 1969; ():Suppl 5:816-8. PubMed ID: 5402310
    [No Abstract]   [Full Text] [Related]  

  • 92. Intravenous ascorbic acid as a treatment for severe jellyfish stings.
    Kumar S; Miranda-Massari JR; Gonzalez MJ; Riordan HD
    P R Health Sci J; 2004 Jun; 23(2):125-6. PubMed ID: 15377062
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Effects of high dose ascorbate administration on L-10 tumor growth in guinea pigs.
    Casciari JJ; Riordan HD; Miranda-Massari JR; Gonzalez MJ
    P R Health Sci J; 2005 Jun; 24(2):145-50. PubMed ID: 16116933
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Intravenous ascorbic acid: protocol for its application and use.
    Riordan HD; Hunninghake RB; Riordan NH; Jackson JJ; Meng X; Taylor P; Casciari JJ; González MJ; Miranda-Massari JR; Mora EM; Rosario N; Rivera A
    P R Health Sci J; 2003 Sep; 22(3):287-90. PubMed ID: 14619456
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Is there hope for drug therapy of cataracts?].
    Koch HR
    Ther Umsch; 1984 Apr; 41(4):229-38. PubMed ID: 6729753
    [No Abstract]   [Full Text] [Related]  

  • 96. Ascorbate (Vit. C) therapy: its role in community health care management.
    Mowle AF
    Australas Nurses J; 1982 May; 11(4):22-5. PubMed ID: 6921986
    [No Abstract]   [Full Text] [Related]  

  • 97. [Pathogenetic rationale for inclusion of vitamin E in combined correction of iron deficiency anemia].
    Kuzdenbaeva RS
    Patol Fiziol Eksp Ter; 2001; (2):25. PubMed ID: 11550365
    [No Abstract]   [Full Text] [Related]  

  • 98. Combined therapy with ascorbic acid and calcitonin for the relief of bone pain in Paget's disease.
    Smethurst M; Basu TK; Gillett MB; Donaldson D; Jordan SJ; Williams DC; Hicklin JA
    Acta Vitaminol Enzymol; 1981; 3(1):8-11. PubMed ID: 7293873
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Ultrarapid anesthesia in otorhinolaryngology; experiences with a new drug; sodium salt of N-methyl-isopropyl-barbituric acid with 4 volume % of diethyl-ether].
    PIVOTTI G; PESAVENTO G
    Acta Anaesthesiol; 1957; 8(4):329-36. PubMed ID: 13468950
    [No Abstract]   [Full Text] [Related]  

  • 100. The efficacy of ascorbate treatment after severe experimental alkali burns depends upon the route of administration.
    Pfister RR; Paterson CA; Spiers JW; Hayes SA
    Invest Ophthalmol Vis Sci; 1980 Dec; 19(12):1526-9. PubMed ID: 7440108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.